š”š²šš š¦ššŗšŗš®šæš
ā¢ Four rare diseases in India now have cheaper treatment options as Indian pharma companies are producing medicines for them, reducing reliance on expensive imported formulations.
ā¢ The annual cost of Nitisinone capsules, used in the treatment of Tyrosinemia Type 1, will be reduced to one-hundredth of the price of the imported medicine.
ā¢ The commercial supply of Hydroxyurea Syrup used in the treatment of sickle cell anemia is likely to begin by March 2024 at a tentative price of Rs 405 per bottle.